天宇股份 (300702)

Zhejiang Tianyu Pharmaceutical Co., Ltd.

ASZ

Tags

Contract Research Organization (CXO)Chemical PharmaceuticalsPrivate Equity Heavy PositionsHigh-Performing StocksChiNext 200 IndexChiNext HealthcareSZSE Medicine Equal Weight IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE 1000 IndexPrivate PlacementInsurance Heavy HoldingsSME Board Innovation IndexManufacturing IndexCS Pharmaceutical TI IndexCSI 1000 IndexChiNext Basic IndexChiNext Low Volatility IndexZhaoyang 100 IndexZhongchuang Low Volatility IndexZhongchuang 400 IndexCOVID-19 DrugsZhejiang

K-Line Chart

No K-line data available

Company NameZhejiang Tianyu Pharmaceutical Co., Ltd.
Listing Date2017-09-19
Issue Price22.41RMB
Registered Capital34797.715910k RMB
Legal RepresentativeTu Yongjun
Registered AddressHuangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, registration, production, and sales of chemical active pharmaceutical ingredients (APIs) and intermediates.
Company ProfileZhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993. It is a joint-stock limited company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company has a registered capital of 90 million yuan, occupies an area of over 650 acres, and currently employs more than 2,000 people. The company is a National Torch Plan Key High-Tech Enterprise and has been listed among the top ten industrial enterprises in Huangyan District, Taizhou City for five consecutive years. The company has established a "Provincial-level Enterprise Technology Center," a "Provincial-level Enterprise Research Institute for Cardiovascular and Cerebrovascular Drugs," and jointly built development laboratories with Zhejiang University and Fudan University.

Stock Details

1. Key Indicators

  • Total Shares(W): 34797.72
  • Circulating A-Shares(W): 21116.45
  • Earnings Per Share(RMB): 0.6300
  • Net Assets Per Share(RMB): 10.6912
  • Operating Revenue(W RMB): 228698.11
  • Total Profit(W RMB): 23499.73
  • Net Profit Attributable to Parent(W RMB): 22093.30
  • Net Profit Growth Rate(%): 159.57
  • Weighted Return on Equity(%): 6.1200
  • Operating Cash Flow Per Share(RMB): 0.6190
  • Undistributed Profit Per Share(RMB): 5.3825
  • Capital Reserve Per Share(RMB): 4.0950

2. Main Business

The main business covers:

  • Research, production, and sales of intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms.

3. Company Basic Information

  • Company Name: Zhejiang Tianyu Pharmaceutical Co., Ltd.
  • Listing Date: 2017-09-19
  • Industry: Pharmaceutical Manufacturing
  • Address: Huangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province
  • Website: www.tianyupharm.com
  • Company Profile：The company's predecessor, Zhejiang Tianyu Pharmaceutical Chemical Co., Ltd., was established on February 14, 2003. On April 8, 2011, the company resolved to transform into a joint stock company. The company is primarily engaged in the research, production, and sales of intermediates, APIs, and finished dosage forms.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jiangsu Zhaoxin Private Fund Management Co., Ltd. - Zhaoxin Liaowang No.1 Private Securities Investment Fund Private Securities Investment Fund 2154.49 10.20
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 614.40 2.91
3 Zhejiang Tianyu Pharmaceutical Co., Ltd. - 2024 Employee Stock Ownership Plan Asset Management Plan 355.01 1.68
4 Guotai Jiatai Equity Special Pension Product - China Merchants Bank Co., Ltd. Asset Management Plan 330.09 1.56
5 Golden Eagle Fund - Tibet Trust - Jintong No.33 Collective Fund Trust Plan - Golden Eagle Youxuan No.210 Single Asset Management Plan Asset Management Plan 236.62 1.12
6 Guotai Asset Management Co., Ltd. - Social Security Fund 2103 Portfolio Social Security Fund 229.25 1.09
7 Xinao Pharmaceutical Health Hybrid Securities Investment Fund A Class Fund 56.65 0.27
8 Xinao Small and Medium Cap Hybrid Securities Investment Fund A Class Fund 33.11 0.16
9 Xiangcai Pharmaceutical Health Hybrid Securities Investment Fund A Class Fund 27.38 0.13
10 Orient CSI A500 Index Enhanced Securities Investment Fund A Class Fund 16.50 0.08

5. Concept Sectors

  • CXO Concept
  • Synthetic Biology
  • High-Performance Stocks
  • Heavily Held by Private Funds
  • Chuangye 200 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information